Table 4.
Grouped-level disorder | Count | Overall prevalence | 95% CI* | Female prevalence % | Male prevalence % | P-value |
---|---|---|---|---|---|---|
Dental | 378 | 19.2 | 17.5–21.0 | 21.2 | 17.3 | 0.028 |
Enteropathy | 270 | 13.7 | 12.2–15.3 | 11.6 | 15.9 | 0.006 |
Skin | 250 | 12.7 | 11.2–14.2 | 11.6 | 13.7 | 0.159 |
Aural | 197 | 10.0 | 8.7–11.4 | 9.8 | 10.3 | 0.718 |
Obesity | 164 | 8.3 | 7.1–9.6 | 10.2 | 6.4 | 0.002 |
Anal sac | 128 | 6.5 | 5.4–7.7 | 6.0 | 7.0 | 0.367 |
Mass-associated | 123 | 6.2 | 5.2–7.4 | 5.7 | 6.8 | 0.311 |
Ophthalmological | 112 | 5.7 | 4.7–6.8 | 5.7 | 5.7 | 0.991 |
Cardiac | 85 | 4.3 | 3.5–5.3 | 5.6 | 3.1 | 0.005 |
Neoplastic | 83 | 4.2 | 3.3–5.2 | 3.9 | 4.6 | 0.438 |
Musculoskeletal | 80 | 4.1 | 3.2–5.0 | 4.1 | 4.1 | 0.993 |
Parasitic | 77 | 3.9 | 3.1–4.9 | 4.3 | 3.6 | 0.411 |
Claw/nail | 75 | 3.8 | 3.0–4.7 | 3.0 | 4.5 | 0.075 |
Traumatic injury | 70 | 3.5 | 2.8–4.5 | 3.0 | 4.2 | 0.147 |
Behavioural | 65 | 3.3 | 2.6–4.2 | 3.0 | 3.7 | 0.382 |
The P-value reflects prevalence comparison between females and males. P-values that are less than 0.05 are highlighted in bold. *CI confidence interval